Patents Assigned to BELLWETHER BIO, INC.
  • DIAGNOSIS OF CANCER OR OTHER PHYSIOLOGICAL CONDITION USING CIRCULATING NUCLEIC ACID FRAGMENT SENTINEL ENDPOINTS
    Publication number: 20230348993
    Abstract: Methods for diagnosis of cancer or other physiological conditions using cDNA as sentinel endpoints are disclosed.
    Type: Application
    Filed: April 25, 2023
    Publication date: November 2, 2023
    Applicant: BELLWETHER BIO, INC.
    Inventors: Matthew William SNYDER, Robert Navid Farjad AZAD, Jay SHENDURE
  • DETERMINATION OF A PHYSIOLOGICAL CONDITION WITH NUCLEIC ACID FRAGMENT ENDPOINTS
    Publication number: 20230287516
    Abstract: Methods for diagnosis of one or more physiological conditions using cfDNAs are disclosed. One embodiment of the invention is the computer implemented analysis of mapped circulating cell-free DNA fragment endpoint locations using a hidden Markov model to detect the presence of absence of cancer in a test subject. Another embodiment is a system for implementing the analysis of circulating cell-free DNA to detect the presence of absence of cancer using a hidden Markov model.
    Type: Application
    Filed: May 12, 2023
    Publication date: September 14, 2023
    Applicant: BELLWETHER BIO, INC.
    Inventors: Matthew William SNYDER, Jason Thaddeus DEAN